Genesis Investment Properties

Genesis Investment Properties is owned by Genesis Biotechnology Group.

Genesis Biotechnology Group has 3 subsidiaries including Genesis Drug Discovery & Development, Genesis Investment Properties and Medical Diagnostic Laboratories.

They are in:

• Biotechnology75%
• Real Estate25%

View the org chart displaying its 11 main executives

Most searched biographies at Genesis Investment Properties

• Eli Mordechai, Chief Executive Officer
• Elka Devash, Principal
• Sophia Lee, Director of Finance

Create your alert
to follow the executive moves at Genesis Investment Properties.

Genesis Biotechnology Group has 3,112 competitors including Emeria Group (France), JLL (United States (USA)) and Signa (Austria).

Popular M&A news in Real Estate

• Blackstone Group has announced the acquisition of AIR Communities  (posted on April 10 2024).
• Overmoon has just announced a $80 Million fundraising (posted on February 20 2024).
• Evergrande Group has filed for bankruptcy protection Evergrande Group  (posted on January 31 2024).

Popular contacts in Real Estate

• Amit Jain - Group Chief Executive Officer at Emaar
• Nahil Wijesuriya - Chairman of the Board at East-West Properties
• Stephen CuUnjieng - Director at Century Properties Group

Learn more about the Real Estate industry >

Press releases by Genesis Investment Properties

• News | Genesis Investment Properties
• Genesis Investment Properties

Social media about Genesis Investment Properties

• Genesis Investment Properties on Wikipedia, Google News & Yahoo Finance
• Genesis Investment Properties on LinkedIn, Twitter & YouTube

Contact by email its executives including Eli Mordechai

Call Genesis Investment Properties at +1 609...

View the org chart

Register to receive your alert

Report an error